Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease

Serum vascular endothelial growth factor (VEGF) increases with Alzheimer’s disease (AD) severity and may prevent cognitive decline. However, information on the influence of AD drug therapy on circulating VEGF is limited. This study assessed changes in serum VEGF levels and its association with clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, X Anton, Alvarez, Irene, Martinez, Antia, Romero, Iria, Benito, Concha, Suarez, Irene, Mourente, Silvia, Fantini, Manuel, Figueroa, Jesús, Aleixandre, Manuel, Linares, Carlos, Muresanu, Dafin, Winter, Stefan, Moessler, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710915/
https://www.ncbi.nlm.nih.gov/pubmed/32640027
http://dx.doi.org/10.1093/ijnp/pyaa046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710915/
https://www.ncbi.nlm.nih.gov/pubmed/32640027
http://dx.doi.org/10.1093/ijnp/pyaa046

Ejemplares similares